Terms: = Pancreatic cancer AND MLH1, COCA2, 4292, ENSG00000076242, hMLH1, FCC2, HNPCC2, P40692, MGC5172, HNPCC AND Treatment
32 results:
1. The relationship between DNA mismatch repair gene and other prognostic parameters in pancreatic adenocarcinoma.
Urganci N; Kepil N; Ergun S; Bakkaloglu OK
J Surg Oncol; 2024 Apr; 129(5):876-884. PubMed ID: 38173349
[TBL] [Abstract] [Full Text] [Related]
2. Analysis of Plasma Circulating Tumor DNA in Borderline Resectable pancreatic cancer Treated with Neoadjuvant Modified FOLFIRINOX: Clinical Relevance of DNA Damage Repair Gene Alteration Detection.
Lim DH; Yoon H; Kim KP; Ryoo BY; Lee SS; Park DH; Song TJ; Hwang DW; Lee JH; Song KB; Kim SC; Hong SM; Hyung J; Yoo C
Cancer Res Treat; 2023 Oct; 55(4):1313-1320. PubMed ID: 37139665
[TBL] [Abstract] [Full Text] [Related]
3. pancreatic cancer with Mutation in BRCA1/2, mlh1, and APC Genes: Phenotype Correlation and Detection of a Novel Germline BRCA2 Mutation.
Vietri MT; D'Elia G; Caliendo G; Albanese L; Signoriello G; Napoli C; Molinari AM
Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205366
[TBL] [Abstract] [Full Text] [Related]
4. Haploinsufficiency by minute MutL homolog 1 promoter DNA methylation may represent unique phenotypes of microsatellite instability-gastric carcinogenesis.
Harada H; Nie Y; Araki I; Soeno T; Chuman M; Washio M; Sakuraya M; Ushiku H; Niihara M; Hosoda K; Kumamoto Y; Naitoh T; Sangai T; Hiki N; Yamashita K
PLoS One; 2021; 16(12):e0260303. PubMed ID: 34936649
[TBL] [Abstract] [Full Text] [Related]
5. A correlation study of mismatch repair immunohistochemical protein expression of pancreatic solid tumors in cytology cell blocks and matching surgical specimens.
Teodosescu A; Chan I; Elder J; Wu M
Diagn Cytopathol; 2021 Jun; 49(6):700-705. PubMed ID: 33615705
[TBL] [Abstract] [Full Text] [Related]
6. Silencing of long non-coding RNA FOXD2-AS1 inhibits the progression of gallbladder cancer by mediating methylation of mlh1.
Gao J; Dai C; Yu X; Yin XB; Liao WJ; Huang Y; Zhou F
Gene Ther; 2021 Jun; 28(6):306-318. PubMed ID: 32917950
[TBL] [Abstract] [Full Text] [Related]
7. Exceptional Response to A Single Cycle of Immunotherapy in a Lynch Syndrome Patient with Metastatic pancreatic Adenocarcinoma.
Patil NR; Khan GN
Am J Case Rep; 2020 Jul; 21():e923803. PubMed ID: 32658872
[TBL] [Abstract] [Full Text] [Related]
8. The utility of immunohistochemical testing for mismatch repair proteins in fine needle aspiration specimens of pancreatic adenocarcinoma.
Mettman D; Haer E; Olyaee M; Rastogi A; Madan R; O'Neil M; Kelting S; Dennis K; Fan F
Ann Diagn Pathol; 2020 Aug; 47():151552. PubMed ID: 32570025
[TBL] [Abstract] [Full Text] [Related]
9. Negative prognostic impact of PD-L1 expression in tumor cells of undifferentiated (anaplastic) carcinoma with osteoclast-like giant cells of the pancreas: study of 13 cases comparing ductal pancreatic carcinoma and review of the literature.
Hrudka J; Lawrie K; Waldauf P; Ciprová V; Moravcová J; Matěj R
Virchows Arch; 2020 Nov; 477(5):687-696. PubMed ID: 32424767
[TBL] [Abstract] [Full Text] [Related]
10. Frequency of mismatch repair deficiency in pancreatic ductal adenocarcinoma.
Ahmad-Nielsen SA; Bruun Nielsen MF; Mortensen MB; Detlefsen S
Pathol Res Pract; 2020 Jun; 216(6):152985. PubMed ID: 32360245
[TBL] [Abstract] [Full Text] [Related]
11. Homogeneous MMR Deficiency Throughout the Entire Tumor Mass Occurs in a Subset of Colorectal Neuroendocrine Carcinomas.
Fraune C; Simon R; Hube-Magg C; Makrypidi-Fraune G; Kluth M; Büscheck F; Amin T; Viol F; Fehrle W; Dum D; Höflmayer D; Burandt E; Clauditz TS; Perez D; Izbicki J; Wilczak W; Sauter G; Steurer S; Schrader J
Endocr Pathol; 2020 Jun; 31(2):182-189. PubMed ID: 32144630
[TBL] [Abstract] [Full Text] [Related]
12. A comprehensive analysis of candidate genes in familial pancreatic cancer families reveals a high frequency of potentially pathogenic germline variants.
Earl J; Galindo-Pumariño C; Encinas J; Barreto E; Castillo ME; Pachón V; Ferreiro R; Rodríguez-Garrote M; González-Martínez S; Ramon Y Cajal T; Diaz LR; Chirivella-Gonzalez I; Rodriguez M; de Castro EM; García-Seisdedos D; Muñoz G; Rosa JMR; Marquez M; Malats N; Carrato A
EBioMedicine; 2020 Mar; 53():102675. PubMed ID: 32113160
[TBL] [Abstract] [Full Text] [Related]
13. An Emerging Paradigm for Germline Testing in pancreatic Ductal Adenocarcinoma and Immediate Implications for Clinical Practice: A Review.
Rainone M; Singh I; Salo-Mullen EE; Stadler ZK; O'Reilly EM
JAMA Oncol; 2020 May; 6(5):764-771. PubMed ID: 32053139
[TBL] [Abstract] [Full Text] [Related]
14. Characterization of novel genetic alterations in salivary gland secretory carcinoma.
Na K; Hernandez-Prera JC; Lim JY; Woo HY; Yoon SO
Mod Pathol; 2020 Apr; 33(4):541-550. PubMed ID: 31822803
[TBL] [Abstract] [Full Text] [Related]
15. Comprehensive cancer Panel Sequencing Defines Genetic Diversity and Changes in the Mutational Characteristics of pancreatic cancer Patients Receiving Neoadjuvant treatment.
Yoon KA; Woo SM; Kim YH; Kong SY; Lee MK; Han SS; Kim TH; Lee WJ; Park SJ
Gut Liver; 2019 Nov; 13(6):683-689. PubMed ID: 30970447
[TBL] [Abstract] [Full Text] [Related]
16. Germline Variants and Risk for pancreatic cancer: A Systematic Review and Emerging Concepts.
Zhan W; Shelton CA; Greer PJ; Brand RE; Whitcomb DC
Pancreas; 2018 Sep; 47(8):924-936. PubMed ID: 30113427
[TBL] [Abstract] [Full Text] [Related]
17. Expression of the DNA repair gene mlh1 correlates with survival in patients who have resected pancreatic cancer and have received adjuvant chemoradiation: NRG Oncology RTOG Study 9704.
Lawrence YR; Moughan J; Magliocco AM; Klimowicz AC; Regine WF; Mowat RB; DiPetrillo TA; Small W; Simko JP; Golan T; Winter KA; Guha C; Crane CH; Dicker AP
Cancer; 2018 Feb; 124(3):491-498. PubMed ID: 29053185
[TBL] [Abstract] [Full Text] [Related]
18. Promoter hypermethylation in plasma-derived cell-free DNA as a prognostic marker for pancreatic adenocarcinoma staging.
Henriksen SD; Madsen PH; Larsen AC; Johansen MB; Pedersen IS; Krarup H; Thorlacius-Ussing O
Int J Cancer; 2017 Dec; 141(12):2489-2497. PubMed ID: 28857158
[TBL] [Abstract] [Full Text] [Related]
19. cancer risk and survival in
Møller P; Seppälä TT; Bernstein I; Holinski-Feder E; Sala P; Gareth Evans D; Lindblom A; Macrae F; Blanco I; Sijmons RH; Jeffries J; Vasen HFA; Burn J; Nakken S; Hovig E; Rødland EA; Tharmaratnam K; de Vos Tot Nederveen Cappel WH; Hill J; Wijnen JT; Jenkins MA; Green K; Lalloo F; Sunde L; Mints M; Bertario L; Pineda M; Navarro M; Morak M; Renkonen-Sinisalo L; Valentin MD; Frayling IM; Plazzer JP; Pylvanainen K; Genuardi M; Mecklin JP; Moeslein G; Sampson JR; Capella G;
Gut; 2018 Jul; 67(7):1306-1316. PubMed ID: 28754778
[TBL] [Abstract] [Full Text] [Related]
20. DNA-repair defects in pancreatic neuroendocrine tumors and potential clinical applications.
Liu IH; Ford JM; Kunz PL
Cancer Treat Rev; 2016 Mar; 44():1-9. PubMed ID: 26924193
[TBL] [Abstract] [Full Text] [Related]
[Next]
